X0609 4 2026-03-10-05:00 false 0000924515 GUIDED THERAPEUTICS INC GTHP 0001348439 Imhoff John E false 5835 PEACHTREE CORNERS EAST SUITE B PEACHTREE CORNERS GA 30092 true false true false false Common Stock 2026-03-26-05:00 4 J false 2157 A 21055256 D Preferred Series F Stock 2026-03-26-05:00 4 J false 10 D 0 D Common Stock 2026-03-26-05:00 4 J false 40000 A 21095256 D Common Stock 2026-03-31-05:00 4 C false 157417 0.07 A 21252673 D Stock Options 0.29 2026-03-10-05:00 4 A false 110000 0.00 A 2036-03-09 Common Stock 110000 110000 D Convertible Promissory Note 0.07 2026-03-31-05:00 4 C false 157417 0.07 D 2026-03-31 2027-02-28 Common Stock 156086 110000 D One-fourth of the shares subject to the award vested on March 10, 2026; the remaining shares will vest monthly, starting on June 10, 2026, subject to the reporting person's continued service on each such date, until the award is fully vested on March 10, 2029. These shares were issued for payment of accrued dividends on the reporting individual's Series F preferred stock, at a conversion price of $0.2773. On March 26, 2026, Mr. Imhoff converted 10 shares of Series F preferred stock into 40,000 shares of common stock. The Series F preferred stock had a stated value of $1,000 and $0.25 conversion price. On March 31, 2026, Dr. Imhoff converted $11,019.18 outstanding under a September 25, 2025 Convertible Promissory Note into 157,417 shares of common stock at a conversion price of $0.07 per share. The amount converted consisted of $10,000 of principal and $1,019.18 of accrued interest. Following the reported conversion, $110,000 of principal remains outstanding under the convertible promissory note. Upon the occurrence of an event of default, the remaining balance is convertible into common stock at a variable conversion price determined in accordance with the terms of the note. /s/ John E. Imhoff 2026-04-07